$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi

$mrvi Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000182323923000014 Filed on February 28, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$204.7M	$883.0M
YoY Change	-10.39%	10.48%
Cost Of Revenue	$53.25M	$169.0M
YoY Change	31.06%	20.2%
Gross Profit	$151.5M	$714.0M
YoY Change	-19.36%	8.41%
Gross Profit Margin	73.99%	80.87%
Selling, General & Admin	$37.20M	$129.3M
YoY Change	35.02%	29.18%
% of Gross Profit	24.56%	18.1%
Research & Development	$4.411M	$18.37M
YoY Change	-48.55%	20.7%
% of Gross Profit	2.91%	2.57%
Depreciation & Amortization	$8.198M	$7.566M
YoY Change	138.04%	17.98%
% of Gross Profit	5.41%	1.06%
Operating Expenses	$42.21M	$147.6M
YoY Change	14.94%	28.06%
Operating Profit	$109.2M	$574.2M
YoY Change	-27.69%	3.53%
Interest Expense	-$7.842M	$20.41M
YoY Change	76.9%	-32.54%
% of Operating Profit	-7.18%	3.56%
Other Income/Expense, Net	-$5.528M	-$358.0K
YoY Change	95.34%	-228.32%
Pretax Income	$95.88M	$551.5M
YoY Change	-33.34%	3.9%
Income Tax	$8.447M	$60.81M
% Of Pretax Income	8.81%	11.03%
Net Earnings	$37.63M	$220.2M
YoY Change	-32.12%	20.97%
Net Earnings / Revenue	18.38%	24.94%
Basic Earnings Per Share		$1.67
Diluted Earnings Per Share	$0.28	$1.67
COMMON SHARES
Basic Shares Outstanding		131.5M shares
Diluted Shares Outstanding		255.3M shares

Balance Sheet

Concept	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$632.1M	$632.1M
YoY Change	14.67%	14.67%
Cash & Equivalents	$632.1M
Short-Term Investments
Other Short-Term Assets	$25.80M	$25.80M
YoY Change	30.97%	30.97%
Inventory	$43.15M	$43.15M
Prepaid Expenses
Receivables	$138.6M	$138.6M
Other Receivables	$8.190M	$8.190M
Total Short-Term Assets	$847.9M	$847.9M
YoY Change	14.58%	14.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$52.69M	$116.6M
YoY Change	13.73%	22.18%
Goodwill	$283.7M
YoY Change	85.69%
Intangibles	$216.7M
YoY Change	84.28%
Long-Term Investments
YoY Change
Other Assets	$115.6M	$817.5M
YoY Change	116.25%	0.62%
Total Long-Term Assets	$1.434B	$1.434B
YoY Change	21.74%	21.74%
TOTAL ASSETS
Total Short-Term Assets	$847.9M	$847.9M
Total Long-Term Assets	$1.434B	$1.434B
Total Assets	$2.282B	$2.282B
YoY Change	18.98%	18.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.991M	$5.991M
YoY Change	-26.53%	-26.53%
Accrued Expenses	$53.37M	$50.63M
YoY Change	54.37%	72.56%
Deferred Revenue	$3.088M
YoY Change	-69.76%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.440M	$5.440M
YoY Change	-9.33%	-9.33%
Total Short-Term Liabilities	$110.1M	$110.1M
YoY Change	17.45%	17.45%
LONG-TERM LIABILITIES
Long-Term Debt	$522.0M	$522.0M
YoY Change	-0.49%	-0.49%
Other Long-Term Liabilities	$68.98M	$744.9M
YoY Change	67.96%	-1.27%
Total Long-Term Liabilities	$591.0M	$1.267B
YoY Change	4.48%	-0.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$110.1M	$110.1M
Total Long-Term Liabilities	$591.0M	$1.267B
Total Liabilities	$1.377B	$1.737B
YoY Change	0.3%	8.38%
SHAREHOLDERS EQUITY
Retained Earnings	$404.8M
YoY Change	119.31%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$545.2M	$545.2M
YoY Change
Total Liabilities & Shareholders Equity	$2.282B	$2.282B
YoY Change	18.98%	18.98%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$37.63M	$220.2M
YoY Change	-32.12%	20.97%
Depreciation, Depletion And Amortization	$8.198M	$7.566M
YoY Change	138.04%	17.98%
Cash From Operating Activities	$99.33M	$536.0M
YoY Change	70.78%	45.42%
INVESTING ACTIVITIES
Capital Expenditures	$6.214M	$17.09M
YoY Change	-209.75%	15.08%
Acquisitions		$239.0M
YoY Change
Other Investing Activities	-$12.31M	-$250.5M
YoY Change		-307.89%
Cash From Investing Activities	-$18.52M	-$267.6M
YoY Change	227.09%	-353.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net		$13.90M
YoY Change		131.58%
Cash From Financing Activities	-66.12M	-$187.5M
YoY Change	34.95%	17.89%
NET CHANGE
Cash From Operating Activities	99.33M	$536.0M
Cash From Investing Activities	-18.52M	-$267.6M
Cash From Financing Activities	-66.12M	-$187.5M
Net Change In Cash	14.69M	$80.87M
YoY Change	318.93%	-74.34%
FREE CASH FLOW
Cash From Operating Activities	$99.33M	$536.0M
Capital Expenditures	$6.214M	$17.09M
Free Cash Flow	$93.12M	$518.9M
YoY Change	45.89%	46.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001823239
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201602Member
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39725
CY2022	dei	Entity Registrant Name EntityRegistrantName	Maravai LifeSciences Holdings, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2786970
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	10770 Wateridge Circle
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
CY2022	dei	City Area Code CityAreaCode	858
CY2022	dei	Local Phone Number LocalPhoneNumber	546-0004
CY2022	dei	Security12b Title Security12bTitle	Class A common stock, $0.01 par value
CY2022	dei	Trading Symbol TradingSymbol	MRVI
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	3121100000	usd
CY2022	dei	Auditor Firm AuditorFirmId	42
CY2022	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2022	dei	Auditor Location AuditorLocation	San Mateo, California
CY2022Q4	us-gaap	Cash Cash	632138000	usd
CY2021Q4	us-gaap	Cash Cash	551272000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	138624000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	117512000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	43152000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	51557000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25798000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19698000	usd
CY2022Q4	us-gaap	Government Assistance Amount Cumulative Current GovernmentAssistanceAmountCumulativeCurrent	8190000	usd
CY2021Q4	us-gaap	Government Assistance Amount Cumulative Current GovernmentAssistanceAmountCumulativeCurrent	0	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	847902000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	740039000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	52694000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46332000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	283668000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	152766000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	216663000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	117571000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	765799000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	808117000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	115589000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53451000	usd
CY2022Q4	us-gaap	Assets Assets	2282315000	usd
CY2021Q4	us-gaap	Assets Assets	1918276000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5991000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8154000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	53371000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	34574000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3088000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10211000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	42254000	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	34838000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5440000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	110144000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	93777000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	521997000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	524591000	usd
CY2022Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	675956000	usd
CY2021Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	713481000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	68975000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	41066000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1377072000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1372915000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	137898000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	128386000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	404766000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	184561000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	545218000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	315499000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	360025000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	229862000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	905243000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	545361000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2282315000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1918276000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	883001000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	799240000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	284098000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	168957000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	140561000	usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	79649000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	129259000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	100064000	usd
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	94245000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18369000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15219000	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9304000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7800000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	11249000	usd
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2020	us-gaap	Sale Leaseback Transaction Current Period Gain Recognized SaleLeasebackTransactionCurrentPeriodGainRecognized	19002000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	308785000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	244595000	usd
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	164196000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	574216000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	554645000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	119902000	usd
CY2022	us-gaap	Interest Expense InterestExpense	20414000	usd
CY2021	us-gaap	Interest Expense InterestExpense	30260000	usd
CY2020	us-gaap	Interest Expense InterestExpense	30740000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	2338000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-208000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7592000	usd
CY2022	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	4102000	usd
CY2021	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	-6101000	usd
CY2020	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	0	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-358000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	279000	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	126000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	551472000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	530765000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	81696000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60809000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61515000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2880000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	490663000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	78816000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	270458000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	287213000	usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-10156000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	220205000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	182037000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	88972000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.67
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.59
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.43
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.56
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.36
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131545000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	114791000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10351000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	255323000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	257803000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28908000	shares
CY2022	us-gaap	Profit Loss ProfitLoss	490663000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	78816000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	55000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-44000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	490663000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	469305000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	78772000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	270458000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	287224000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-10156000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	220205000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	182081000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	88928000	usd
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	144627000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	9140000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	88880000	usd
	us-gaap	Limited Liability Company Llc Members Equity Unit Based Compensation LimitedLiabilityCompanyLLCMembersEquityUnitBasedCompensation	3276000	usd
	us-gaap	Profit Loss ProfitLoss	88216000	usd
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	166427000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000	usd
CY2020Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1754432000	usd
CY2020Q4	mrvi	Noncontrolling Interest Decrease From Purchase Of Preexisting Units NoncontrollingInterestDecreaseFromPurchaseOfPreexistingUnits	1424327000	usd
CY2020Q4	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	0	usd
CY2020Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	33658000	usd
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20387000	usd
CY2020Q4	us-gaap	Profit Loss ProfitLoss	-20831000	usd
CY2020Q4	mrvi	Adjustments To Additional Paid In Capital Tax Receivable Agreement Impact AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreementImpact	42776000	usd
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	966000	usd
CY2020Q4	us-gaap	Profit Loss ProfitLoss	11431000	usd
CY2020Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	16000	usd
CY2020Q4	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	8171000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	154746000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
CY2021	mrvi	Adjustments To Additional Paid In Capital Tax Receivable Agreement Impact AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreementImpact	53000000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1670000	usd
CY2021	mrvi	Noncontrolling Interest Increase From Cash Distribution Value NoncontrollingInterestIncreaseFromCashDistributionValue	5220000	usd
CY2021	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	0	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10458000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	153492000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	55000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	545361000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2305000	usd
CY2022	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	0	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18670000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	150065000	usd
CY2022	mrvi	Adjustments To Additional Paid In Capital Change In Deferred Tax Asset AdjustmentsToAdditionalPaidInCapitalChangeInDeferredTaxAsset	1691000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	490663000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	905243000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	490663000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	78816000	usd
CY2022	mrvi	Depreciation Including Adjustments DepreciationIncludingAdjustments	7566000	usd
CY2021	mrvi	Depreciation Including Adjustments DepreciationIncludingAdjustments	6413000	usd
CY2020	mrvi	Depreciation Including Adjustments DepreciationIncludingAdjustments	5517000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24269000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18339000	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20320000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6268000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8792000	usd
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2788000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2676000	usd
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1825000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	18670000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	10458000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	24629000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-208000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-7592000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	42318000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	46904000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5464000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7800000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	11249000	usd
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2022	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	0	usd
CY2021	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	0	usd
CY2020	us-gaap	Sale Leaseback Transaction Current Period Gain Recognized SaleLeasebackTransactionCurrentPeriodGainRecognized	19002000	usd
CY2022	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	usd
CY2021	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	usd
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	2881000	usd
CY2022	mrvi	Payments Of Financing Costs Operating Activities PaymentsOfFinancingCostsOperatingActivities	0	usd
CY2021	mrvi	Payments Of Financing Costs Operating Activities PaymentsOfFinancingCostsOperatingActivities	0	usd
CY2020	mrvi	Payments Of Financing Costs Operating Activities PaymentsOfFinancingCostsOperatingActivities	3239000	usd
CY2022	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	-4102000	usd
CY2021	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	6101000	usd
CY2020	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	0	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7993000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	281000	usd
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2419000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22272000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	70391000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	33144000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9459000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21574000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19099000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	52873000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9513000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5518000	usd
CY2022	mrvi	Increase Decrease In Government Funding Receivable IncreaseDecreaseInGovernmentFundingReceivable	-16973000	usd
CY2021	mrvi	Increase Decrease In Government Funding Receivable IncreaseDecreaseInGovernmentFundingReceivable	0	usd
CY2020	mrvi	Increase Decrease In Government Funding Receivable IncreaseDecreaseInGovernmentFundingReceivable	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1578000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	676000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1176000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8503000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3457000	usd
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	17777000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-7123000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-67851000	usd
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	77220000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	3829000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4521000	usd
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2519000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	535977000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	368570000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	152187000	usd
CY2022	mrvi	Payments To Acquire Assets Net Of Cash Acquired PaymentsToAcquireAssetsNetOfCashAcquired	238969000	usd
CY2021	mrvi	Payments To Acquire Assets Net Of Cash Acquired PaymentsToAcquireAssetsNetOfCashAcquired	0	usd
CY2020	mrvi	Payments To Acquire Assets Net Of Cash Acquired PaymentsToAcquireAssetsNetOfCashAcquired	3024000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17090000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14850000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25408000	usd
CY2022	mrvi	Proceeds From Government Assistance Allocated To Property And Equipment ProceedsFromGovernmentAssistanceAllocatedToPropertyAndEquipment	1105000	usd
CY2021	mrvi	Proceeds From Government Assistance Allocated To Property And Equipment ProceedsFromGovernmentAssistanceAllocatedToPropertyAndEquipment	0	usd
CY2020	mrvi	Proceeds From Government Assistance Allocated To Property And Equipment ProceedsFromGovernmentAssistanceAllocatedToPropertyAndEquipment	0	usd
CY2022	mrvi	Finance Lease Prepayments Lease Not Yet Commenced FinanceLeasePrepaymentsLeaseNotYetCommenced	13278000	usd
CY2021	mrvi	Finance Lease Prepayments Lease Not Yet Commenced FinanceLeasePrepaymentsLeaseNotYetCommenced	0	usd
CY2020	mrvi	Finance Lease Prepayments Lease Not Yet Commenced FinanceLeasePrepaymentsLeaseNotYetCommenced	0	usd
CY2022	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	0	usd
CY2021	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	548000	usd
CY2020	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	34500000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	620000	usd
CY2021	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	119957000	usd
CY2020	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-267612000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	105655000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6068000	usd
CY2022	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	150206000	usd
CY2021	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	153451000	usd
CY2020	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	97051000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	8455000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	609000000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	9295000	usd
CY2022	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	usd
CY2021	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	usd
CY2020	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	9140000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	13895000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000000	usd
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	411875000	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1439000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2020	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	201000	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	120005000	usd
CY2022	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
CY2021	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
CY2020	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	208053000	usd
CY2022	mrvi	Payments To Acquire Limited Liability Company Units PaymentsToAcquireLimitedLiabilityCompanyUnits	0	usd
CY2021	mrvi	Payments To Acquire Limited Liability Company Units PaymentsToAcquireLimitedLiabilityCompanyUnits	0	usd
CY2020	mrvi	Payments To Acquire Limited Liability Company Units PaymentsToAcquireLimitedLiabilityCompanyUnits	1424324000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	33658000	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2358000	usd
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1709000	usd
CY2020	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	321000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-187499000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-159049000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53212000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-88000	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	80866000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	315088000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	211484000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	551272000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	236184000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24700000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	632138000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	551272000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	236184000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	20198000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	27234000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	28916000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	23032000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	22473000	usd
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	5006000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1701000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2149000	usd
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1990000	usd
CY2022	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
CY2021	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
CY2020	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	6000000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	17513000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	mrvi	Capitalized Costs Under Lease Financing Transaction CapitalizedCostsUnderLeaseFinancingTransaction	0	usd
CY2021	mrvi	Capitalized Costs Under Lease Financing Transaction CapitalizedCostsUnderLeaseFinancingTransaction	0	usd
CY2020	mrvi	Capitalized Costs Under Lease Financing Transaction CapitalizedCostsUnderLeaseFinancingTransaction	700000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7800000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	10000000	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0	usd
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	46422000	usd
CY2022	mrvi	Conversion Of Stock Amount Converted For Blocker Mergers ConversionOfStockAmountConvertedForBlockerMergers	0	usd
CY2021	mrvi	Conversion Of Stock Amount Converted For Blocker Mergers ConversionOfStockAmountConvertedForBlockerMergers	0	usd
CY2020	mrvi	Conversion Of Stock Amount Converted For Blocker Mergers ConversionOfStockAmountConvertedForBlockerMergers	782073000	usd
CY2022	mrvi	Conversion Of Stock Deferred Tax Asset ConversionOfStockDeferredTaxAsset	0	usd
CY2021	mrvi	Conversion Of Stock Deferred Tax Asset ConversionOfStockDeferredTaxAsset	423361000	usd
CY2020	mrvi	Conversion Of Stock Deferred Tax Asset ConversionOfStockDeferredTaxAsset	441984000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	366179000	usd
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	389546000	usd
CY2022	mrvi	Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction StockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
CY2021	mrvi	Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction StockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
CY2020	mrvi	Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction StockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	2816000	usd
CY2022	mrvi	Noncash Or Part Noncash Divestiture Receivable From Lessor Funded Financing NoncashOrPartNoncashDivestitureReceivableFromLessorFundedFinancing	0	usd
CY2021	mrvi	Noncash Or Part Noncash Divestiture Receivable From Lessor Funded Financing NoncashOrPartNoncashDivestitureReceivableFromLessorFundedFinancing	0	usd
CY2020	mrvi	Noncash Or Part Noncash Divestiture Receivable From Lessor Funded Financing NoncashOrPartNoncashDivestitureReceivableFromLessorFundedFinancing	1987000	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires the Company to make judgements, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenue and expenses, and related disclosures. These estimates form the basis for judgments the Company makes about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company bases its estimates and judgments on historical experience and on various other assumptions that the Company believes are reasonable under the circumstances. These estimates are based on management’s knowledge about current events and expectations about actions the Company may undertake in the future. Significant estimates include, but are not limited to, the measurement of right-of-use assets and lease liabilities and related incremental borrowing rate, the payable to related parties pursuant to the Tax Receivable Agreement (as defined in Note 14), the realizability of our net deferred tax assets, and valuation of goodwill and intangible assets acquired in business combinations. Actual results could differ materially from those estimates.</span></div>
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4800000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	12600000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	883001000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	799240000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	284098000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	2500000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	1300000	usd
CY2020	us-gaap	Advertising Expense AdvertisingExpense	1200000	usd
CY2022	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Paid TaxReceivableAgreementPercentageOfTaxBenefitsPaid	0.85
CY2022	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Unpaid TaxReceivableAgreementPercentageOfTaxBenefitsUnpaid	0.15
CY2022	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Paid TaxReceivableAgreementPercentageOfTaxBenefitsPaid	0.85
CY2022	mrvi	Conversion Of Stock Conversion Ratio ConversionOfStockConversionRatio	1
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2200000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	300000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit RiskFinancial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. The Company maintains the majority of its cash balances at multiple financial institutions that management believes are of high-credit quality and financially stable. Cash is deposited with major financial institutions in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash is held. The Company provides credit, in the normal course of business, to international and domestic distributors as well as certain customers, which are geographically dispersed. The Company attempts to limit its credit risk by performing ongoing credit evaluations of its customers and maintaining adequate allowances for potential credit losses.
CY2022Q4	us-gaap	Goodwill Goodwill	283700000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	152800000	usd
CY2022	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reporting_unit
CY2022Q4	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reporting_unit
CY2021Q4	us-gaap	Goodwill Goodwill	152766000	usd
CY2022	us-gaap	Goodwill Transfers GoodwillTransfers	130902000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	283668000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	318082000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	101419000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	216663000	usd
CY2022	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P9Y3M18D
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	194721000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	77150000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	117571000	usd
CY2021	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P8Y1M6D
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	24812000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	24812000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	24669000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	24432000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	23416000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	94522000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	216663000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7800000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	13486000	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19726000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	21950000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	21382000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7716000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10449000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	43152000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	51557000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19502000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12532000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	52694000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46332000	usd
CY2022	us-gaap	Depreciation Depreciation	7600000	usd
CY2021	us-gaap	Depreciation Depreciation	6400000	usd
CY2020	us-gaap	Depreciation Depreciation	5600000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63896000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	49095000	usd
CY2022Q4	mrvi	Prepaid Lease Payments PrepaidLeasePayments	27253000	usd
CY2021Q4	mrvi	Prepaid Lease Payments PrepaidLeasePayments	0	usd
CY2022Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	11362000	usd
CY2021Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	541000	usd
CY2022Q4	mrvi	Business Combination Indemnification Assets Carrying Value BusinessCombinationIndemnificationAssetsCarryingValue	7682000	usd
CY2021Q4	mrvi	Business Combination Indemnification Assets Carrying Value BusinessCombinationIndemnificationAssetsCarryingValue	0	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	5396000	usd
CY2021Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	3815000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	115589000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53451000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	19873000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18894000	usd
CY2022Q4	mrvi	Inventory Holdback Liability Current InventoryHoldbackLiabilityCurrent	10000000	usd
CY2021Q4	mrvi	Inventory Holdback Liability Current InventoryHoldbackLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	7700000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	145000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6269000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3722000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4093000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2897000	usd
CY2022Q4	mrvi	Contract With Customer Liability Current Customer Deposits ContractWithCustomerLiabilityCurrentCustomerDeposits	1665000	usd
CY2021Q4	mrvi	Contract With Customer Liability Current Customer Deposits ContractWithCustomerLiabilityCurrentCustomerDeposits	2429000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1029000	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1296000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	102000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2742000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5089000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	53371000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	34574000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	51556000	usd
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	400000000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	40906000	usd
CY2022Q4	mrvi	Accrued Retention Payments Noncurrent AccruedRetentionPaymentsNoncurrent	9324000	usd
CY2021Q4	mrvi	Accrued Retention Payments Noncurrent AccruedRetentionPaymentsNoncurrent	0	usd
CY2022Q4	mrvi	Business Combination Tax Liability Noncurrent BusinessCombinationTaxLiabilityNoncurrent	7682000	usd
CY2021Q4	mrvi	Business Combination Tax Liability Noncurrent BusinessCombinationTaxLiabilityNoncurrent	0	usd
CY2022Q4	mrvi	Other Liabilities Miscellaneous Noncurrent OtherLiabilitiesMiscellaneousNoncurrent	413000	usd
CY2021Q4	mrvi	Other Liabilities Miscellaneous Noncurrent OtherLiabilitiesMiscellaneousNoncurrent	160000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	68975000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	41066000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63896000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	49095000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6269000	usd
CY2020Q4	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	50000000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	17513000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3722000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	51556000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	40906000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	8800000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	8792000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	2742000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	1759000	usd
CY2022	us-gaap	Lease Cost LeaseCost	11542000	usd
CY2021	us-gaap	Lease Cost LeaseCost	10551000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y10M24D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.051
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	7049000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	6335000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	9886000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10304000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	10386000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9455000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	7959000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	31177000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	79167000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	21342000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	57825000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5440000	usd
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	544000000	usd
CY2018Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	52000000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	11123000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	13409000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	527437000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	530591000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5440000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	521997000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	524591000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5440000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5440000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	5440000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	516800000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	538560000	usd
CY2022Q4	mrvi	Conversion Of Stock Conversion Ratio ConversionOfStockConversionRatio	1
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022	mrvi	Conversion Of Stock Conversion Ratio ConversionOfStockConversionRatio	1
CY2022	mrvi	Conversion Of Stock Conversion Ratio ConversionOfStockConversionRatio	1
CY2021Q4	mrvi	Noncontrolling Interest Common Units Acquired NoncontrollingInterestCommonUnitsAcquired	2732919	shares
CY2021Q4	mrvi	Noncontrolling Interest Common Units Acquired Price Per Share NoncontrollingInterestCommonUnitsAcquiredPricePerShare	40.25
CY2021Q4	mrvi	Noncontrolling Interest Common Unit Forfeiture Percentage NoncontrollingInterestCommonUnitForfeiturePercentage	0.02036
CY2022	mrvi	Preferred Units Cumulative Annual Dividend Percentage PreferredUnitsCumulativeAnnualDividendPercentage	0.080
CY2022	mrvi	Preferred Units Cumulative Annual Dividend Additional Rate Percentage PreferredUnitsCumulativeAnnualDividendAdditionalRatePercentage	0.040
CY2022	mrvi	Preferred Units Cumulative Annual Dividend Additional Rate Percentage PreferredUnitsCumulativeAnnualDividendAdditionalRatePercentage	0.040
CY2022	us-gaap	Profit Loss ProfitLoss	490663000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	78816000	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	15270000	usd
CY2022	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	270458000	usd
CY2021	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	287213000	usd
CY2020	mrvi	Net Income Loss Attributable To Common Noncontrolling Interest NetIncomeLossAttributableToCommonNoncontrollingInterest	-13342000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	220205000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	182037000	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	76888000	usd
CY2022	us-gaap	Dilutive Securities DilutiveSecurities	87000	usd
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	132000	usd
CY2020	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022	mrvi	Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock	205984000	usd
CY2021	mrvi	Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock	220187000	usd
CY2020	mrvi	Dilutive Securities Effect On Basic Earnings Per Share Conversion Of Class B Common Stock DilutiveSecuritiesEffectOnBasicEarningsPerShareConversionOfClassBCommonStock	-8802000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	426276000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	402356000	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	68086000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131545000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	114791000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10351000	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	109000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	153000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1000	shares
CY2022	mrvi	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock	123669000	shares
CY2021	mrvi	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock	142859000	shares
CY2020	mrvi	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Common Stock IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfCommonStock	18556000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	255323000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	257803000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28908000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.67
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.59
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.43
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.67
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.56
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.36
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2856000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	367000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1586000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1409000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.47
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	16846000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1709000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	23.81
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	26.08
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	221000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	31.64
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2893000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.45
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M24D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	726000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	28.75
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y2M12D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	7700000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4300000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	27700000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18670000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10458000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24629000	usd
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	166400000	usd
CY2020Q4	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	1000	shares
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	551472000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	530853000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	82012000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-88000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-316000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	551472000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	530765000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	81696000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	16312000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	9291000	usd
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6093000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2173000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1623000	usd
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2251000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	6000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3697000	usd
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	18491000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	14611000	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	8344000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	39924000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	36564000	usd
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3922000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	2394000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	10340000	usd
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1542000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	42318000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	46904000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5464000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60809000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61515000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2880000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.006
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.022
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.003
CY2022	mrvi	Effective Income Tax Rate Reconciliation Deferred Tax Revaluation Percent EffectiveIncomeTaxRateReconciliationDeferredTaxRevaluationPercent	0.003
CY2021	mrvi	Effective Income Tax Rate Reconciliation Deferred Tax Revaluation Percent EffectiveIncomeTaxRateReconciliationDeferredTaxRevaluationPercent	0
CY2020	mrvi	Effective Income Tax Rate Reconciliation Deferred Tax Revaluation Percent EffectiveIncomeTaxRateReconciliationDeferredTaxRevaluationPercent	-0.018
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.103
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.114
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.189
CY2022	mrvi	Effective Income Tax Rate Reconciliation Gain On Liquidation Of Subsidiary Percent EffectiveIncomeTaxRateReconciliationGainOnLiquidationOfSubsidiaryPercent	0
CY2021	mrvi	Effective Income Tax Rate Reconciliation Gain On Liquidation Of Subsidiary Percent EffectiveIncomeTaxRateReconciliationGainOnLiquidationOfSubsidiaryPercent	-0.007
CY2020	mrvi	Effective Income Tax Rate Reconciliation Gain On Liquidation Of Subsidiary Percent EffectiveIncomeTaxRateReconciliationGainOnLiquidationOfSubsidiaryPercent	0.027
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.001
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.013
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.004
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.015
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.006
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.007
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.005
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.110
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.116
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.035
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	636498000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	675855000	usd
CY2022Q4	mrvi	Deferred Tax Assets Deductions For Tax Receivable Agreement DeferredTaxAssetsDeductionsForTaxReceivableAgreement	148681000	usd
CY2021Q4	mrvi	Deferred Tax Assets Deductions For Tax Receivable Agreement DeferredTaxAssetsDeductionsForTaxReceivableAgreement	154093000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	3265000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1131000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1249000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	789575000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	831197000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23776000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23080000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	765799000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	808117000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	700000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	9400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	3300000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6300000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	200000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1900000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	1000000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	241000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	220000	usd
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	208000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	130000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	232000	usd
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	62000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	6775000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	889000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	211000	usd
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	50000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6257000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	241000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	220000	usd
CY2022	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Paid TaxReceivableAgreementPercentageOfTaxBenefitsPaid	0.85
CY2022	mrvi	Tax Receivable Agreement Percentage Of Tax Benefits Paid TaxReceivableAgreementPercentageOfTaxBenefitsPaid	0.85
CY2022	mrvi	Assumed Effective Income Tax Rate Reconciliation Percent AssumedEffectiveIncomeTaxRateReconciliationPercent	0.467
CY2022	mrvi	Assumed Effective Income Tax Rate Reconciliation Business Income Deduction Unavailable Percent AssumedEffectiveIncomeTaxRateReconciliationBusinessIncomeDeductionUnavailablePercent	0.541
CY2022Q4	mrvi	Tax Distribution Payable TaxDistributionPayable	0	usd
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1600000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1300000	usd
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1000000	usd
CY2022	mrvi	Conversion Of Stock Conversion Ratio ConversionOfStockConversionRatio	1
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	883001000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	799240000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	284098000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	24269000	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	18339000	usd
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20320000	usd
CY2022	us-gaap	Depreciation Depreciation	7566000	usd
CY2021	us-gaap	Depreciation Depreciation	6413000	usd
CY2020	us-gaap	Depreciation Depreciation	5593000	usd
CY2022	us-gaap	Interest Expense InterestExpense	20414000	usd
CY2021	us-gaap	Interest Expense InterestExpense	30260000	usd
CY2020	us-gaap	Interest Expense InterestExpense	30740000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	2338000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2022	mrvi	Corporate Costs Net Of Eliminations CorporateCostsNetOfEliminations	55378000	usd
CY2021	mrvi	Corporate Costs Net Of Eliminations CorporateCostsNetOfEliminations	43265000	usd
CY2020	mrvi	Corporate Costs Net Of Eliminations CorporateCostsNetOfEliminations	18398000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-7800000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	13362000	usd
CY2021	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	44000	usd
CY2020	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	3857000	usd
CY2022	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	usd
CY2021	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	usd
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	2881000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18670000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10458000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24629000	usd
CY2022	us-gaap	Management Fee Expense ManagementFeeExpense	0	usd
CY2021	us-gaap	Management Fee Expense ManagementFeeExpense	0	usd
CY2020	us-gaap	Management Fee Expense ManagementFeeExpense	680000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	11249000	usd
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2020	us-gaap	Sale Leaseback Transaction Current Period Gain Recognized SaleLeasebackTransactionCurrentPeriodGainRecognized	19002000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2416000	usd
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1508000	usd
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	395000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1078000	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	2383000	usd
CY2020	us-gaap	Professional Fees ProfessionalFees	9784000	usd
CY2022	mrvi	Business Combination Acquisition Related Tax Adjustment BusinessCombinationAcquisitionRelatedTaxAdjustment	-349000	usd
CY2021	mrvi	Business Combination Acquisition Related Tax Adjustment BusinessCombinationAcquisitionRelatedTaxAdjustment	0	usd
CY2020	mrvi	Business Combination Acquisition Related Tax Adjustment BusinessCombinationAcquisitionRelatedTaxAdjustment	0	usd
CY2021	us-gaap	Profit Loss ProfitLoss	469250000	usd
CY2022	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	-4102000	usd
CY2021	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	6101000	usd
CY2020	mrvi	Gain Loss On Tax Receivable Agreement GainLossOnTaxReceivableAgreement	0	usd
CY2022	mrvi	Ceo Transition Costs CEOTransitionCosts	-2426000	usd
CY2021	mrvi	Ceo Transition Costs CEOTransitionCosts	0	usd
CY2020	mrvi	Ceo Transition Costs CEOTransitionCosts	0	usd
CY2022	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	-1814000	usd
CY2021	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	0	usd
CY2020	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	-7592000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	551472000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	530765000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	81696000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60809000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61515000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2880000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	490663000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	78816000	usd

Files In Submission

Name	View Source	Status
mrvi-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mrvi-20221231_lab.xml	Edgar Link	unprocessable
0001823239-23-000014-index-headers.html	Edgar Link	pending
0001823239-23-000014-index.html	Edgar Link	pending
0001823239-23-000014.txt	Edgar Link	pending
0001823239-23-000014-xbrl.zip	Edgar Link	pending
exhibit104-mrvixformofsmac.htm	Edgar Link	pending
exhibit105-mrvixformofsmai.htm	Edgar Link	pending
exhibit106-mrvixformofamen.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mrvi-20221231.htm	Edgar Link	pending
mrvi-20221231.xsd	Edgar Link	pending
mrvi-20221231_g1.jpg	Edgar Link	pending
mrvi-20221231_g2.jpg	Edgar Link	pending
mrvi-20221231_g3.jpg	Edgar Link	pending
mrvi-20221231_g4.jpg	Edgar Link	pending
mrvi-20221231_g5.jpg	Edgar Link	pending
mrvi-20221231_g6.jpg	Edgar Link	pending
mrvi-20221231_g7.jpg	Edgar Link	pending
mrvi-20221231_cal.xml	Edgar Link	unprocessable
mrvi-20221231_def.xml	Edgar Link	unprocessable
mrvi-2022form10xkxex211xli.htm	Edgar Link	pending
mrvi-2022form10xkxex231xco.htm	Edgar Link	pending
mrvi-2022form10xkxex311xce.htm	Edgar Link	pending
mrvi-2022form10xkxex321xce.htm	Edgar Link	pending
mrvi-2022form10xkxex322xcf.htm	Edgar Link	pending
mrvi-2022form10xkxex42xdes.htm	Edgar Link	pending
mrvi-form202210xkxex312xcf.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
mrvi-20221231_htm.xml	Edgar Link	completed
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi

2022 Q4 Form 10-K Financial Statement

#000182323923000014 Filed on February 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi

2022 Q4 Form 10-K Financial Statement

#000182323923000014 Filed on February 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock $mrvi